With big problems. Comes a big IDEA.
As long-time Veeva users, we’ve experienced first-hand the challenges faced by advertising agencies, brand managers, legal, regulatory, and medical affairs teams. We've encountered it all: cumbersome referencing, inefficient workflows, lengthy MLR review meetings, and costly delays that push back new product launches or required product updates. We created ERMA—to drive REAL change in the Pharmaceutical, Biotechnology, Medical Device, Gene Therapy, and Animal Sciences sectors. Every feature of ERMA has been thoughtfully crafted based on decades of experiences and interactions with project teams from multiple life sciences companies. We've taken this real-world input and used it as the foundation of our ERMA mission and vision.
Julia Gardner
Founder
Founder of MAAST DIGITAL, Life Sciences and Healthcare Digital Agency (10 years)
Julia is the Founder of MAAST Digital, a leading digital marketing agency specializing in life sciences. With extensive experience as a Brand Strategy and Account Lead, she has partnered with Fortune 500 companies across the U.S., EMEA, LATAM, and Canada. A seasoned Veeva user for over 15 years, Julia has a deep understanding of the challenges and inefficiencies that pharmaceutical companies face daily. Her extensive industry insight contributed to the development of ERMA, a solution crafted from 15 years of feedback from agencies, medical teams, regulatory, legal, and brand managers. She has worked with top-tier pharmaceutical and biotech clients, including Merck, Celgene, Allergan, Bausch Health, Neurogene, Purdue, EMD Serono, Forest Labs, Amgen, Roche, GSK, Scilex, Pharming, Novartis Gene Therapy, Recordati Rare Diseases, Nuvectis, and Galderma.
Ray Hwang
CTO
Co-Founder of Original Function, Development Agency (10 years)
Ray is the founder of Original Function, an on-demand technology development firm specializing in custom software solutions. With over 15 years of experience in the tech industry, Ray began his career as a developer at MRM Worldwide, where he led teams to create interactive digital experiences for clients like Bristol-Myers Squibb (BMS) and WebMD. His expertise in developing custom web, mobile, and SaaS applications helped him establish a strong foundation in the technology space. As the Chief Technology Officer at ERMA, Ray oversees all technical operations and leads development teams to deliver efficient, reliable solutions. Passionate about staying at the forefront of emerging technologies, Ray ensures that his projects incorporate the latest tools and best practices to meet the highest standards of quality and performance. In addition to his work at Original Function, Ray teaches computer science, math, and physics at private schools across New Jersey, sharing his knowledge and inspiring the next generation of tech leaders.
Jennifer Segovia
UX & Design
Co-Founder of MUXA Design, User Research, Design (5 years)
Jennifer is a passionate and results-driven product design leader with extensive experience in creating user-centered strategies, research, and designs that drive business and financial success. Fascinated by technology, human behavior, and microinteractions, she leverages both qualitative and quantitative research to tackle complex challenges, enhance user experiences, and align with business objectives. Jennifer has worked with Deloitte and TripAdvisor demonstrating strong leadership capabilities, managing and mentoring UX teams, facilitating discovery workshops, and developing resources that streamline the design process.
Tyler Chen
Tech Operations Lead
Co-Founder of Original Function, Development Agency (10 years)
Tyler is the founder of Original Function, an on-demand technology development firm specializing in custom software solutions. For more than 20 years, he has worked in the sports and healthcare industries at companies such as Bristol-Myers Squibb, Street & Smith’s SportsBusiness Journal, DIRECTV, and various ad agencies in New York City. Tyler is a seasoned digital executive with extensive experience in producing marketing content, developing web applications, and managing teams and projects of all types and sizes for global brands and top agencies around the world.
Our Respected Advisors
The ERMA team and its advisors have the right skill set and experience to turn this into a successful story
Stacy Hoffmann
Executive Director, Commercial Effectiveness, Zevra Pharmaceuticals
Former Senior Director of Training and Development at AveXis, and Director of Commercial Operations at Lundbeck.
Jaimie Melendez
Strategic Operations, Research and Product Development, CSL
Former Director, Emerging Technology Partnership and Innovation at Johnson & Johnson. Additionally, Associate Director, Technology Partnership and Business Development at Merck.
Ilze Antons
MS, RAC, Senior Director, Regulatory Affairs, Founder
Former Senior Director of Regulatory Affairs at Lundbeck Pharma. Founder of Kurins Consulting. Manages all aspects of regulatory advertising and promotion in the pharmaceutical/biotech industry.
Arvind Sreedharan
Sr. VP, Business Operations, Neurogene Inc.
Three decades of commercial experience. Former VP, of U.S. Commercial Operations for AveXis, the company that developed Zolgensma®, an FDA-approved treatment for spinal muscular atrophy; acquired by Novartis for $8.7 billion.
Stacy Hoffmann
Executive Director, Commercial Effectiveness, Zevra Pharmaceuticals
Former Senior Director of Training and Development at AveXis, and Director of Commercial Operations at Lundbeck.
Jaimie Melendez
Strategic Operations, Research and Product Development, CSL
Former Director, Emerging Technology Partnership and Innovation at Johnson & Johnson. Additionally, Associate Director, Technology Partnership and Business Development at Merck.
Ilze Antons
MS, RAC, Senior Director, Regulatory Affairs, Founder
Former Senior Director of Regulatory Affairs at Lundbeck Pharma. Founder of Kurins Consulting. Manages all aspects of regulatory advertising and promotion in the pharmaceutical/biotech industry.
Arvind Sreedharan
Sr. VP, Business Operations, Neurogene Inc.
Three decades of commercial experience. Former VP, of U.S. Commercial Operations for AveXis, the company that developed Zolgensma®, an FDA-approved treatment for spinal muscular atrophy; acquired by Novartis for $8.7 billion.